Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970
- PMID: 1576492
- DOI: 10.1002/bjs.1800790404
Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970
Abstract
In this review of English language publications from 1970, 5-year survival rates after surgery for gastric cancer have been analysed. While the proportion of patients coming to operation has fallen from 92 per cent before 1970 to 71 per cent by 1990, the proportion of operated patients undergoing resection has increased from 37 per cent before 1970 to 48 per cent before 1990. This change suggests improved preoperative staging leading to better patient selection for operation. The 5-year survival rate following all resections has increased significantly from 20.7 per cent before 1970 to 28.4 per cent before 1990, an increase of 7.7 per cent (95 per cent confidence interval 7.1-8.3 per cent). The 5-year survival rate following curative or radical resection has risen from 37.6 to 55.4 per cent over the same period, an increase of 17.8 per cent (95 per cent confidence interval 17.1-18.5 per cent). It is likely that this improvement has contributed to the decrease in the mortality rate from gastric cancer. Comparison of Japanese series with others suggests that diagnosis and treatment of the disease at an earlier stage will result in an even greater increase in 5-year survival rates outside Japan. Of the papers studied, 56 per cent were excluded from analysis, the majority because the data provided about 5-year survival rates were insufficient or the survival calculations inappropriate. Results of survival after operations for gastric cancer should be calculated and presented in a standardized manner.
Similar articles
-
Improving survival in gastric cancer: review of operative mortality in English language publications from 1970.Br J Surg. 1991 Jul;78(7):771-6. doi: 10.1002/bjs.1800780703. Br J Surg. 1991. PMID: 1873699 Review.
-
Gastric cancer: a 25-year review.Br J Surg. 1989 Jun;76(6):535-40. doi: 10.1002/bjs.1800760604. Br J Surg. 1989. PMID: 2758258
-
Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy.Br J Surg. 1988 Feb;75(2):106-9. doi: 10.1002/bjs.1800750205. Br J Surg. 1988. PMID: 3349292
-
Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.Br J Surg. 2000 May;87(5):618-26. doi: 10.1046/j.1365-2168.2000.01425.x. Br J Surg. 2000. PMID: 10792320
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
Cited by
-
Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer.Virchows Arch. 2013 Oct;463(4):489-95. doi: 10.1007/s00428-013-1461-x. Epub 2013 Aug 4. Virchows Arch. 2013. PMID: 23913168
-
Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer.Dig Dis Sci. 2011 Mar;56(3):698-706. doi: 10.1007/s10620-010-1346-7. Epub 2010 Aug 5. Dig Dis Sci. 2011. PMID: 20686847
-
HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer.Cancer Immunol Immunother. 1997 Oct;45(1):53-9. doi: 10.1007/s002620050400. Cancer Immunol Immunother. 1997. PMID: 9353427 Free PMC article. Clinical Trial.
-
The value of expression of M2-PK and VEGF in patients with advanced gastric cancer.Cell Biochem Biophys. 2013;67(3):1033-9. doi: 10.1007/s12013-013-9601-0. Cell Biochem Biophys. 2013. PMID: 23625175 Free PMC article.
-
DWI as a Quantitative Biomarker in Predicting Chemotherapeutic Efficacy at Multitime Points on Gastric Cancer Lymph Nodes Metastases.Medicine (Baltimore). 2016 Mar;95(13):e3236. doi: 10.1097/MD.0000000000003236. Medicine (Baltimore). 2016. PMID: 27043694 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical